Inspections, Compliance, Enforcement, and Criminal Investigations
NorthWest Pharmacy c/o Pharmawest Pharmacy - Close Out Letter 6/28/12
| Public Health Service Food and Drug Administration |
Silver Spring, MD 20993-0002 |
Department of Health and Human ServicesJune 28, 2012
NorthWest Pharmacy c/o Pharmawest Pharmacy
Unit #101 20560 56th Avenue
Langley, BC, Canada V3A 3Y8
To Whom It May Concern:
The Food and Drug Administration (FDA) has completed an evaluation of your pharmacy’s corrective actions in response to our Warning Letter dated May 24, 2012. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your pharmacy from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your pharmacy to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed.
Sincerely,
/s/
Thomas Christl, Office Director (Acting)
Office of Drug Security, Integrity and Recalls
Office of Compliance
Center for Drug Evaluation and Research
cc: John A. Meyers, Taylor McCaffrey LLP
400 St. Mary Avenue
9th Floor
Winnipeg, Manitoba, Canada R3C 4K5
jamyers@tmlawyers.com
